This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
S. A. Bacanu , B. Devlin , K. V. Chowdari , S. T. DeKosky , V. L. Nimgaonkar and R. A. Sweet (2005). Heritability of psychosis in Alzheimer disease. American Journal of Geriatric Psychiatry, 13, 624–627.
L. L. Barnes , R. S. Wilson , J. A. Schneider , J. L. Bienias , D. A. Evans and D. A. Bennett (2003). Gender, cognitive decline, and risk of AD in older persons. Neurology, 60, 1777–1781.
L. Berg (1998). Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Archives of Neurology, 55, 326–335.
K. Bertram , M. B. McQueen , K. Mullin , D. Blacker and R. E. Tanzi (2007). Systematic Meta-Analysis of Alzheimer Disease Genetic Association Studies: The AlzGene Database. Nature Genetics, 39, 17–23.
P. Bretsky , J. M. Guralnik , L. Launer , M. Albert and T. E. Seeman (2003). The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 1077–1081.
E. H. Corder (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.
S. Craft (1998). Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology, 51, 149–153.
H. H. Dodge , Y. Du , J. A. Saxton and M. Ganguli (2006). Cognitive domains and trajectories of functional independence in nondemented elderly persons. Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 61, 1330–1337.
M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
D. G. Healy (2006). Case-control studies in the genomic era: a clinician's guide. Lancet Neurology, 5, 701–707.
V. S. Helgeson , P. Snyder and H. Seltman (2004). Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychology, 23, 3–15.
P. Hollingworth (2007). Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B, 841–848.
P. Holmans (2005). Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 135B, 24–32.
B. D. Hoyt , P. J. Massman , C. Schatschneider , N. Cooke and R. S. Doody (2005). Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Archives of Neurology, 62, 454–459.
B. L. Jones , D. S. Nagin and K. Roeder (2001). A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods and Research, 29, 374–393.
M. I. Kamboh , C. E. Aston and R. F. Hamman (1995). The relationship of APOE polymorphism and cholesteral levels in normoglycemic and diabetic subjects in biethnic population from the San Luis Valley, Colorado. Atherosclerosis, 112, 145–159.
T. Kleiman (2006). Apolipoprotein E ϵ4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dementia and Geriatric Cognitive Disorders, 22, 73–82.
E. Leisch (2004). FlexMix: a general framework for finite mixture models and latent class regression in R. Journal of Statistical Software, 11, 1–18.
O. L. Lopez , L. H. Kuller , A. Fitzpatrick , D. Ives , J. T. Becker and N. Beauchamp (2003). Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology, 22, 1–12.
U. M. Mann , E. Mohr , M. Gearing and T. N. Chase (1992). Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles. Journal of Neurology, Neurosurgery and Psychiatry, 55, 956–959.
C. A. Martins , A. Oulhaj , C. A. de Jager and J. H. Williams (2005). APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology, 65, 1888–1893.
I. G. McKeith (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47, 1113–1124.
G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34, 939–944.
R. O'Hara , B. Sommer , N. Way , H. C. Kraemer , J. Taylor and G. Murphy (2008). Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein ϵ4 allele. Journal of Psychiatric Research, 42, 199–204.
D. X. Rasmusson , K. A. Carson , R. Brookmeyer , C. Kawas and J. Brandt (1996). Predicting rate of cognitive decline in probable Alzheimer's disease. Brain and Cognition, 31, 133–147.
S. A. Ropacki and D. V. Jeste (2005). Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. American Journal of Psychiatry, 162, 2022–2030.
N. Scarmeas (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 62, 1601–1608.
G. Schwarz (1978). Estimating the dimension of a model. Annals of Statistics, 6, 461–464.
S. L. Tyas (2007). Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. American Journal of Epidemiology, 165, 1231–1238.